Elisabeth K.
- Country
- The Netherlands
- Department
- Neonatology
Research Overview
- Efficacy and Safety of ELGN-2112 in Treating Intestinal Malabsorption in Preterm Infants: A Double-Blind, Randomized, Placebo-Controlled Study
- Safety Assessment of ELGN-2112 (Insulin Human) in Preterm Infants with Intestinal Malabsorption: A Double-Blind, Randomized, Placebo-Controlled Study
- Evaluation of Allopurinol Sodium for Cerebral and Cardiac Protection in Neonates with Critical Congenital Heart Disease Undergoing Cardiopulmonary Bypass
Data & Insights
Has run more than one trial at 14 of 27 partner sites.
Specializations
Neonatal Gastroenterology
The investigator specializes in studying intestinal malabsorption conditions in premature infants, with particular focus on those born before 26 weeks gestational age and infants with intrauterine growth restriction.
- Preterm infant nutrition
- Enteral feeding optimization
- Gastrointestinal development in premature infants
Their research encompasses nutritional interventions and feeding strategies for vulnerable preterm populations.
Pediatric Cardiology
The investigator focuses on critical congenital heart disease in newborns, particularly studying protective interventions during cardiac surgery with cardiopulmonary bypass.
- Neonatal cardiac surgery
- Perioperative care
- Cardioprotective strategies
Their work involves early postnatal interventions and perioperative management protocols.
Neonatal Neurology
The investigator studies brain injury prevention in newborns with cardiac conditions, focusing on neuroprotective strategies during cardiac surgical procedures.
- Neurological outcomes in cardiac surgery
- Brain protection protocols
- Neuroimaging in newborns
Their research includes evaluation of brain injury through post-operative MRI assessment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.